Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB0003340550 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 2.44% 1.05 1.00 1.05 1.075 1.025 1.025 4,386,395 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 0.6 -1.1 -0.3 - 11

Feedback PLC Papworth NHS Hosp - contract renewal with Bleepa

21/05/2020 7:00am

UK Regulatory (RNS & others)

Feedback (LSE:FDBK)
Historical Stock Chart

From May 2020 to Jul 2020

Click Here for more Feedback Charts.


RNS Number : 5474N

Feedback PLC

21 May 2020

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

Feedback plc

Royal Papworth Hospital NHS Foundation Trust renews contract with Feedback and adopts Bleepa (R)

-- Contract renewal incorporates use of Bleepa(R) , the medical grade imaging-based communications platform

   --    Second NHS Trust to adopt Bleepa(R) 

London, 21 May 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces Royal Papworth Hospital NHS Foundation Trust ("Trust") has renewed its contract for clinical PACS (picture archiving and communication system) services with Feedback Medical Ltd, a wholly owned subsidiary of the Company. The renewal will incorporate an upgrade to service, providing the Trust access to Bleepa (R) , Feedback's flagship imaging-based communication platform.

The contract, set for a term of 14 months, rel ates to Feedback's Cadran PACS which has provided core medical imaging services to the Trust since 2001. The contract includes the use of Bleepa (R) as an upgrade to Cadran Web Viewer and will see Bleepa (R) made available to all clinicians at the Trust.

Royal Papworth Hospital is the UK's leading heart and lung hospital, treating more than 100,000 patients each year. Since carrying out the UK's first successful heart transplant in 1979, the hospital now performs more heart, heart-lung and lung transplants each year than any other UK centre. In addition to transplantation, Royal Papworth Hospital has the UK's largest Respiratory Support and is one of five UK centres providing Extra Corporeal Membrane Oxygenation (ECMO) to patients experiencing severe respiratory failure.

For Feedback, the contract marks the second NHS site to adopt Bleepa (R) as a core imaging tool and is further recognition of the potential that Bleepa (R) has to enhance clinical care delivery. The first site was the Pennine Acute NHS Hospitals Trust which is using Bleepa (R) to support frontline staff to manage Covid-19 patients.

Tom Oakley, CEO of Feedback plc, said:

"Papworth has been a longstanding customer of Feedback and we are delighted that they recognise the value of Bleepa (R) as part of this renewal. Enabling critical review at the push of a button, Bleepa (R) has the functionality to bring significant efficiencies and deliver real time-saving potential for its clinicians. The launch of Bleepa at Papworth is further evidence of the changing needs of frontline clinicians around their interaction with medical imaging and with colleagues, something that we are uniquely positioned to enable. We will now look to continue the spread of Bleepa to other opportunities across the healthcare setting."

Bleepa(R) provides instant and remote access to clinical grade medical images through a zero footprint application. The majority of patient cases require medical imaging which can be seamlessly shared to the entire clinical team through Bleepa (R) . Cases can be discussed through its secure instant messaging and image annotation, allowing comments and treatment decisions to be communicated instantly between team members. Bleepa (R) can be accessed from any internet connected device including phones, tablets, laptops and desktops; clinicians can use their own devices and therefore no additional hardware is required.



 Feedback plc                                   +44 (0)1954 718072 
  Tom Oakley, CEO                       
  Lindsay Melvin, CFO 
 Allenby Capital Limited (Nominated Adviser) 
  David Worlidge / Asha Chotai                  +44 (0)20 3328 5656 
 Peterhouse Capital Limited (Joint Broker) 
  Lucy Williams / Duncan Vasey                  +44 (0)20 7469 0936 
 Stanford Capital Partners Limited (Joint 
  Patrick Claridge / John Howes                 +44 20 3815 8880 
 Instinctif Partners                            +44 (0)20 7457 2020 
  Melanie Toyne-Sewell / Phillip Marriage        +44 7890 022 814 

Notes to editors

About Feedback plc -

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

Feedback has launched Bleepa (R) , a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa , see .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

May 21, 2020 02:00 ET (06:00 GMT)

1 Year Feedback Chart

1 Year Feedback Chart

1 Month Feedback Chart

1 Month Feedback Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200711 21:35:05